Kolexia
Hofman Paul
Anatomie et cytologie
Hôpital Pasteur
Nice, France
545 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Carcinomes Cellules tumorales circulantes Mélanome Adénocarcinome Adénocarcinome pulmonaire COVID-19

Industries

AstraZeneca
70 collaboration(s)
Dernière en 2023
Janssen
22 collaboration(s)
Dernière en 2023
BMS
12 collaboration(s)
Dernière en 2023
Lilly
12 collaboration(s)
Dernière en 2023

Dernières activités

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
The Lancet regional health. Europe   01 mars 2024
Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer
The Lancet regional health. Europe   01 mars 2024
MRD-LUNG: GUIding Multi-moDal thErapies Against MRD by LiquidBiopsies in Non Small Cell Lung Cancer- GUIDE.MRD-03-NSCLC
Essai Clinique (University Medical Center Groningen)   21 février 2024
Integrating artificial intelligence into lung cancer screening: a randomised controlled trial protocol.
BMJ open   13 février 2024
AIR: Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease
Essai Clinique (CHU Nice)   05 février 2024
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis.
eLife   01 février 2024
Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.
Cancer cell   24 janvier 2024
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Experimental and molecular pathology   20 janvier 2024
Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis.
Healthcare (Basel, Switzerland)   19 janvier 2024
Real-world incidence and risk factors of pneumonitis in chemoradiation plus immune checkpoint inhibitors compared with chemoradiation alone in lung cancer: a retrospective cohort study.
Translational lung cancer research   12 janvier 2024